End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
8,470 KRW | -1.17% | -1.97% | -7.93% |
Business Summary
Number of employees: 100
Sales per Business
KRW in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Biotechnology
96.4
%
| 97,930 | 95.6 % | 86,378 | 96.4 % | -11.80% |
Healthcare
3.6
%
| 4,476 | 4.4 % | 3,262 | 3.6 % | -27.11% |
Sales per region
KRW in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
South Korea
100.0
%
| 102,406 | 100.0 % | 89,569 | 100.0 % | -12.54% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Mi-Ok Kang
CEO | Chief Executive Officer | 54 | - |
Eul-Moon Hwang
CEO | Chief Executive Officer | 72 | 01/04/84 |
Hee-Yong Jung
SAM | Sales & Marketing | 53 | - |
Gwang-Gi Ahn
AUD | Comptroller/Controller/Auditor | 71 | - |
Ki-Taek Choi
AUD | Comptroller/Controller/Auditor | 65 | - |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Eul-Moon Hwang
CEO | Chief Executive Officer | 72 | 01/04/84 |
Ki-Taek Choi
AUD | Comptroller/Controller/Auditor | 65 | - |
Mi-Ok Kang
CEO | Chief Executive Officer | 54 | - |
Geum-Ryong Lee
BRD | Director/Board Member | 70 | - |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 8,910,267 | 6,055,068 ( 67.96 %) | 348,643 ( 3.913 %) | 67.96 % |
Holdings
Name | Equities | % | Valuation |
---|---|---|---|
347,162 | 3.90% | 2,178,931 $ |
Company contact information
SeouLin Bioscience Co., Ltd.
4/F, Korea Bio Park A-Dong 700 Daewangpangyo-ro
13488, Seongnam-si
+
http://www.seoulin.co.krSector
Sales per Business
1st Jan change | Capi. | |
---|---|---|
-7.93% | 52.44M | |
+38.36% | 52.73B | |
+38.59% | 39B | |
-8.63% | 38.52B | |
+25.46% | 30.38B | |
-11.17% | 26.39B | |
+11.44% | 26.08B | |
+45.09% | 14.15B | |
+32.93% | 12.6B | |
-5.30% | 11.51B |
- Stock Market
- Equities
- A038070 Stock
- Company Seoulin Bioscience Co.,Ltd.